Supplemental material
Articles
In situ thermal ablation augments antitumor efficacy of adoptive T cell therapy
Fumito ItoCenter for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA; ;Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA; ;Department of Surgery, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA; Correspondence[email protected]
http://orcid.org/0000-0002-6866-671XView further author information
http://orcid.org/0000-0002-6866-671XView further author information, , , Kevin H. EngDepartment of Biostatistics and Bioinformatics, Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA; http://orcid.org/0000-0001-5636-0812View further author information
http://orcid.org/0000-0001-5636-0812View further author information, , Jason B. MuhitchDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA; ;Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USAhttp://orcid.org/0000-0002-7703-1425View further author information
http://orcid.org/0000-0002-7703-1425View further author information & Sharon S. EvansDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA; Correspondence[email protected]
http://orcid.org/0000-0003-2958-6642View further author information
http://orcid.org/0000-0003-2958-6642View further author information show allRelated Research Data
In situ thermal ablation augments antitumor efficacy of adoptive T cell therapy
Source:
Taylor & Francis
In situ thermal ablation augments antitumor efficacy of adoptive T cell therapy
Source:
Taylor & Francis
In situ thermal ablation augments antitumor efficacy of adoptive T cell therapy
Source:
Taylor & Francis
Linking provided by
